Skip to main content
Premium Trial:

Request an Annual Quote

Biognosys Launches Partnership with CellnTec for MRM-MS Assay Development


Swiss proteomics firm Biognosys has launched a partnership with cell culture company CellnTec to study the proteomics of aging.

Under the partnership, Biognosys has created a custom multiple-reaction monitoring mass spec assay for quantifying proteins linked to aging and screening for anti-aging substances.

The assay quantifies 100 proteins involved in age-related processes. Using it in combination with CellnTec's VitroAge culture medium – which is designed to encourage the natural aging of cultured cells – CellnTec has identified a number of proteins linked to the aging process and aims to develop mechanistic understandings of the anti-aging abilities of various agents.

Financial and other terms of the agreement were not disclosed.